Cancer patients with diabetes have higher mortality rates

Share this content:
Mortality Rates Higher in Cancer Patients With Diabetes
Mortality Rates Higher in Cancer Patients With Diabetes

(HealthDay News) -- The comorbid condition of diabetes may contribute to increased mortality in patients with cancer, according to research published online March 13 in Diabetologia.

Kristina Ranc, of the University of Copenhagen in Denmark, and colleagues examined data from a national registry of all patients diagnosed with cancer from 1995 to 2009. The authors sought to compare mortality rates among cancer patients with and without diabetes.

The researchers found that mortality rates were higher for cancer patients with diabetes than for cancer patients without diabetes. The highest mortality rates were observed among patients with diabetes who were treated with insulin. For insulin-treated patients with diabetes for two years at the time of diagnosis of any type of cancer, mortality rate ratios were 3.7 (95 percent confidence interval [CI], 2.7 to 5.1) for men and 4.4 for women (95 percent CI, 3.1 to 6.5) at one year after cancer diagnosis, and increased to 5 (95 percent CI, 3.5 to 7.0) for men and 6.5 (95 percent CI, 4.2 to 9.3) for women at nine years after cancer diagnosis. Mortality rates also were higher among patients receiving oral hypoglycemic agents for diabetes.

"In conclusion, our study provides strong support for the notion that pre-existing diabetes increases mortality among cancer patients, and that the excess mortality is larger among patients with diabetes treated with oral hypoglycemic agents or, particularly, insulin," the authors write.

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs